Class II
Drug Recall: Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR
PAYLESS COMPOUNDERS, LLC · March 6, 2026
Reason for Recall
Lack of Assurance of Sterility
Distribution
OR
States Affected
OR
Quantity Affected
91 vials
Source: FDA (openFDA Drug Enforcement)
Recall number: D-0471-2026
Status: ongoing
SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.